Immuntherapie:Offener Zugang | 9

Yao Zhang, Ling Li, Yakun Li, Zengmin Yang, Aijing Zhang, Ercui Shen, Yun Liu, Yan Wang, Minghui Zheng, Xiao Chen, Shuming Wu, Haijiang Zhang, Yongjiang Liu

Teile diesen Artikel

Forschungsartikel

Development and Characterization of Neutralizing Antibodies against SARS-CoV-2

Yao Zhang, Ling Li, Yakun Li, Zengmin Yang, Aijing Zhang, Ercui Shen, Yun Liu, Yan Wang, Minghui Zheng, Xiao Chen, Shuming Wu, Haijiang Zhang, Yongjiang Liu

Teile diesen Artikel

Immuntherapie:Offener Zugang
Offener Zugang

Volumen 9, Ausgabe 3 (2023)

Lung Cancer Immunotherapy: Its Advancements and Challenges

Lung Cancer Immunotherapy: Its Advancements and Challenges

Lung Cancer Immunotherapy: Its Advancements and Challenges

Differential Expression Analysis of Natural Killer (NK) Cell Receptor (NKG2D) in Hepatitis C Virus-Infected Chronic Hepatitis and Hepatocellular Patients for the Development of Targeted Immunotherapy

Differential Expression Analysis of Natural Killer (NK) Cell Receptor (NKG2D) in Hepatitis C Virus-Infected Chronic Hepatitis and Hepatocellular Patients for the Development of Targeted Immunotherapy

Differential Expression Analysis of Natural Killer (NK) Cell Receptor (NKG2D) in Hepatitis C Virus-Infected Chronic Hepatitis and Hepatocellular Patients for the Development of Targeted Immunotherapy

Cancer Immunotherapy: Its Types, Applications and Challenges

Colon Cancer: Its Symptoms, Diagnosis, Treatment and Prevention

Benefits of Allergen Immunotherapy and Safety Considerations

Cancer Immunotherapy: Its Types, Applications and Challenges

Colon Cancer: Its Symptoms, Diagnosis, Treatment and Prevention

Benefits of Allergen Immunotherapy and Safety Considerations

Development and Characterization of Neutralizing Antibodies against SARS-CoV-2

Development and Characterization of Neutralizing Antibodies against SARS-CoV-2

Immuntherapie:Offener ZugangOffener Zugang

Volumen 9, Ausgabe 3 (2023)

Immuntherapie:Offener Zugang
Offener Zugang